Outcomes |
Reported in paper (circle) |
Primary outcomes |
|
Outcome 1—Mortality of children in postoperative period |
Yes/No |
Outcome 2—Risk of assisted ventilation (including mask ventilation, laryngeal mask airway and intubation) after extubation |
Yes/No |
Outcome 3—Risk of drug‐related adverse effects |
Bradycardia/Salivation/Vomiting/Others |
Secondary outcomes |
|
Outcome 1—Risk of postoperative residual neuromuscular block: We defined residual neuromuscular block as TOF ratio < 0.9 in acceleromyography (mechanomyography or electromyography) |
Yes/No |
Outcome 2—Time between neostigmine or placebo administration and TOF ratio recovery to 0.9 |
Yes/No |
Outcome 3—Risk of hypoxia after extubation |
Yes/No |
Outcome 4—Length of stay in PACU |
Yes/No |
Subgroups |
Reported in paper |
Definition of residual neuromuscular block |
|
Muscle relaxant |
|
Length of surgery |
|
Age |
Neonate/Younger than 3 years old/Older than 3 years old |
Race |
White/Black/Yellow |